Organized by:
Sponsored by:
INTERNATIONAL MEETING
UPDATE IN ANTITHROMBOTIC TREATMENT 20-21 FEBRUARY 2020
BARCELONA. SPAIN
Organized by:
TECHNICAL SECRETARIAT:
Maria Cubi, 4 - Pral.
08006 Barcelona (SPAIN) Phn. +34 932.388.777
ACREDITATION (PENDING)
AAFF_programa IMAT_240719.indd 2 24/7/19 14:35
09:00|10:00 Controversy: Dual vs Triple Antithrombotic therapy in AF patients undergoing PCI. What’s best?
• I prefer dual ther in most cases
• I prefer triple therapy in most cases 10:00|10:30 Coffee break
10:30|11:00 Special lecture: Antithrombotic therapy in TAVR
11:00|12:00 Round Table discussion: Relevant questions about antithrombotic therapy in ischemic heart disease.
• How to stratify ischemic and bleeding risks in a given patient?
• When to shorten ant when to prolong DAPT?
• How to use cangrelor?
12:00|13:00 Lunch
13:00|14:00 Case-based session: Management of antithrombotic therapy in complex clinical scenarios.
14:00|14:40 Round Table discussion: New strategies of antithrombotic therapy in ischemic heart disease.
• Chairmen
• De-escalation of P2Y12 inhibitors
• Dual therapy with rivaroxaban
• Monotherapy with potent P2Y12 inhibitors 14:40|14:45 Closure
THURSDAY, FEBRUARY 20
15:20|15:30 Welcome
15:30|16:30 Round Table discussion: What is your preferred anticoagulant agent in STEMI patients?
• Unfractionated heparin
• Low-molecular weight heparin
• Bivalirudin
16:30|17:00 Controversy: Pretreatment in NSTEACS 17:00|17:20 Coffee break
17:20|18:20 Case-based session: Management of antithrombotic therapy in complex PCI scenarios
18:20|19:00 Special lecture: Pharmacological characteristics of parenteral antiplatelet agents
FRIDAY, FEBRUARY 21
08:30|09:00 Special lecture: Research in new antithrombotic agents. What’s in the pipeline?
DIRECTORS
A. Cequier | Bellvitge University Hospital. Barcelona. Spain
F.J. Neumann | University Heart Center Freiburg. Bad Krozingen. Germany
CO-DIRECTORS
J.L. Ferreiro | Bellvitge University Hospital. Barcelona. Spain
T. Nührenberg | University Heart Center Freiburg. Bad Krozingen. Germany
CONFIRMED SPEAKERS
F. Alfonso | La Princesa Hospital.
Madrid. Spain
L. Badimón | Santa Creu i Sant Pau Hospital.
Barcelona. Spain
H. Bueno | 12 de Octubre University Hospital.
Madrid. Spain
D. Capodanno | University of Catania.
Catania. Italy
W. Desmet | UZ Leuven.
Leuven. Belgium
J.A. Gómez | Bellvitge University Hospital.
Barcelona. Spain
C. Hamm | University Hospital of Giessen.
Giessen. Germany
G. Montalescot | Pitié-Salpêtrière Hospital.
Paris. France
JP Collet | Pitié-Salpêtrière Hospital.
Paris, France
R. Moreno | De la Paz Hospital.
Madrid. Spain
F. Ribichini | University of Verona.
Verona. Italy
M. Sabaté | Clinic Hospital.
Barcelona. Spain
J. Sanchís | Clinic University Hospital of Valencia.
Valencia. Spain
D. Sibbing | Ludwig-Maximilians-University.
Munich. Germany
M. Valgimigli | University Hospital of Bern.
Bern.Switzerland
P. Verhamme | Centre for Molecular and Vascular Biology.
Leuven. Belgium
S. Windecker | University Hospital of Bern.
Bern. Switzerland
AAFF_programa IMAT_240719.indd 3-4 24/7/19 14:35
